Economics 101: Type 2 diabetes poses a moral hazard for health insurers


Omar Al Ubaydli
  • English
  • Arabic

Almost one in five UAE residents between 20 and 79 years old suffers from type 2 diabetes, a figure that the government calls "shocking". The economics of type 2 diabetes exposes just how challenging it is to design insurance and treatment plans for dealing with the disease.

Type 2 diabetes has two traits that interest economists.

First, in addition to its medical treatments, exercising regularly and maintaining a healthy body weight – measures that require self control rather than deep pockets – drastically reduce the likelihood of the disease developing and worsening. Second, while the direct treatments are relatively cheap, the complications arising from the advancement of type 2 diabetes, such as heart and vascular diseases, amputations and more, are expensive to treat.

This is what renders some sort of medical insurance scheme or universal health care potentially necessary – the medical costs, including those for treating the complications, are beyond what many low-income families could ever summon. If they are not subsidised directly by the government, or indirectly via the insurance premiums paid by healthy people, then sufferers will be forced to forgo treatment.

This thinking underlies the UAE government’s commitment to providing its citizens with free health care. The problem is that assisting sufferers with the high costs of treating type 2 diabetes and its associated complications inadvertently exacerbates those costs at the level of the economy, because of the first trait: the substitutability of medical and lifestyle treatments, also known as the moral hazard problem.

As the 2016 winners of the economics Nobel Prize showed, insuring people undermines their incentive to behave responsibly. In the case of type 2 diabetes, theoretically, the cheaper you make medical treatments, the less effort people will exert in pursuing a healthy lifestyle. Some people in the UAE are understandably reluctant to cut down on kabsa and endless sugar-laden cups of tea, or to force themselves to go to the gym when they could be watching Arabs Got Talent. Free health care renders that reluctance a lot more affordable.

A study by the economists Jonathan Klick (Florida State University) and Thomas Stratmann (George Mason University) examined the roll out of diabetes coverage mandates across 42 states in the US. They demonstrated that the type 2 diabetes sufferers who received a bump in benefits suffered a systematic increase in their body mass index (BMI) compared with non-sufferers, and with sufferers denied the improved health coverage.

The moral hazard problem in health care is like that in car safety, whereby the economist Sam Pletzman hypothesised that forcing people to wear seat belts to decrease deaths would encourage people to drive more dangerously.

A draconian solution to the diabetes moral hazard would be to classify the disease as being completely the responsibility of the citizen, to offer no financial support for the treatment. In this vein another economist, Gordon Tullock, half-jokingly proposed installing spikes aimed at drivers’ foreheads on vehicle steering wheels as a way of encouraging safe driving.

The problem with this approach is that type 2 diabetes is not purely the result of lifestyle decisions – some unlucky people get it for genetic reasons and these are people whom health policy should be looking to assist. There is no way to definitively determine the reason for someone getting the disease, leaving policymakers facing a quandary on how best to balance insurance and incentives.

To bypass the trade-off, the UAE Government has dedicated significant resources to awareness campaigns to help citizens improve their lifestyles, without exposing them to the brutal financial incentives that an uninsured sufferer faces. Global experience suggests limited effectiveness of such measures and reminds us that in the UAE and elsewhere, health policy is genuinely difficult to get right.

We welcome economics questions from our readers via email (omar@omar.ec) or tweet (@omareconomics).

Omar Al Ubaydli is programme director for international and geopolitical studies at the Bahrain Center for Strategic, International and Energy Studies, and an affiliated associate professor of economics at George Mason University.

business@thenational.ae

Follow The National's Business section on Twitter

Russia's Muslim Heartlands

Dominic Rubin, Oxford

How to play the stock market recovery in 2021?

If you are looking to build your long-term wealth in 2021 and beyond, the stock market is still the best place to do it as equities powered on despite the pandemic.

Investing in individual stocks is not for everyone and most private investors should stick to mutual funds and ETFs, but there are some thrilling opportunities for those who understand the risks.

Peter Garnry, head of equity strategy at Saxo Bank, says the 20 best-performing US and European stocks have delivered an average return year-to-date of 148 per cent, measured in local currency terms.

Online marketplace Etsy was the best performer with a return of 330.6 per cent, followed by communications software company Sinch (315.4 per cent), online supermarket HelloFresh (232.8 per cent) and fuel cells specialist NEL (191.7 per cent).

Mr Garnry says digital companies benefited from the lockdown, while green energy firms flew as efforts to combat climate change were ramped up, helped in part by the European Union’s green deal. 

Electric car company Tesla would be on the list if it had been part of the S&P 500 Index, but it only joined on December 21. “Tesla has become one of the most valuable companies in the world this year as demand for electric vehicles has grown dramatically,” Mr Garnry says.

By contrast, the 20 worst-performing European stocks fell 54 per cent on average, with European banks hit by the economic fallout from the pandemic, while cruise liners and airline stocks suffered due to travel restrictions.

As demand for energy fell, the oil and gas industry had a tough year, too.

Mr Garnry says the biggest story this year was the “absolute crunch” in so-called value stocks, companies that trade at low valuations compared to their earnings and growth potential.

He says they are “heavily tilted towards financials, miners, energy, utilities and industrials, which have all been hit hard by the Covid-19 pandemic”. “The last year saw these cheap stocks become cheaper and expensive stocks have become more expensive.” 

This has triggered excited talk about the “great value rotation” but Mr Garnry remains sceptical. “We need to see a breakout of interest rates combined with higher inflation before we join the crowd.”

Always remember that past performance is not a guarantee of future returns. Last year’s winners often turn out to be this year’s losers, and vice-versa.

The%20specs
%3Cp%3E%3Cstrong%3EEngine%3A%3C%2Fstrong%3E%201.8-litre%204-cyl%20turbo%0D%3Cbr%3E%3Cstrong%3EPower%3A%20%3C%2Fstrong%3E190hp%20at%205%2C200rpm%0D%3Cbr%3E%3Cstrong%3ETorque%3A%3C%2Fstrong%3E%20320Nm%20from%201%2C800-5%2C000rpm%0D%3Cbr%3E%3Cstrong%3ETransmission%3A%20%3C%2Fstrong%3ESeven-speed%20dual-clutch%20auto%0D%3Cbr%3E%3Cstrong%3EFuel%20consumption%3A%3C%2Fstrong%3E%206.7L%2F100km%0D%3Cbr%3E%3Cstrong%3EPrice%3A%3C%2Fstrong%3E%20From%20Dh111%2C195%0D%3Cbr%3E%3Cstrong%3EOn%20sale%3A%20%3C%2Fstrong%3ENow%3C%2Fp%3E%0A
Paatal Lok season two

Directors: Avinash Arun, Prosit Roy 

Stars: Jaideep Ahlawat, Ishwak Singh, Lc Sekhose, Merenla Imsong

Rating: 4.5/5

UAE currency: the story behind the money in your pockets
BULKWHIZ PROFILE

Date started: February 2017

Founders: Amira Rashad (CEO), Yusuf Saber (CTO), Mahmoud Sayedahmed (adviser), Reda Bouraoui (adviser)

Based: Dubai, UAE

Sector: E-commerce 

Size: 50 employees

Funding: approximately $6m

Investors: Beco Capital, Enabling Future and Wain in the UAE; China's MSA Capital; 500 Startups; Faith Capital and Savour Ventures in Kuwait